Skip to content
ES
MARKETS / NASDAQ / NOVT
NASDAQ · MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES · LARGE CAP

Novanta Inc. NOVT

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$980.6M
▲ 3.3% YoY
$53.8M
▼ 16.0% YoY
$48.4M
▼ 65.7% YoY
In brief

What this company does

Novanta Inc. is a global supplier of core technology solutions to medical, life science and advanced industrial original equipment manufacturers. As of December 31, 2025, it employed approximately 3,000 people, of which approximately 36% were in the United States, 55% in Europe, and 9% in Asia. During the year ended December 31, 2025, two OEM customers, each operating primarily in the medical end market across multiple product lines, represented approximately 12% and 11%, respectively, of its consolidated revenue. The company reports two reportable segments, identified based on commonality and adjacency of end markets and customers among its individual product lines. The Automation Enabling Technologies segment designs, manufactures and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling and bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, imaging, identification and RFID solutions, advanced motion control solutions, light engines, and integrated operating room technologies. The company was founded and initially incorporated in Massachusetts in 1968 as General Scanning, Inc., which merged with Lumonics Inc. in 1999 to form GSI Lumonics Inc., renamed GSI Group Inc. in 2005 and renamed Novanta Inc. in May 2016.

Written from the business description in NOVANTA INC's annual report to the U.S. Securities and Exchange Commission, filed 23 February 2026. Every sentence was checked against that document before publication.

Growth
USD 980.6M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 980.6 · Net income 53.8
400M800M200920112013201520172019202120232025
Compound annual growth
+4.4%
+10.7%
+10.1%
+8.6%
−10.1%
+3.9%
+4.2%
−10.6%
+3.3%
+3.7%
+57.8%
+48.2%
+37.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +10.7% a year over five years — but profit grew slower: net income at +3.9%, earnings per share at +3.3%.

The share count rose from 0.04B to 0.04B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
5 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 9.6% · Net 5.5%
5%10%-10%-20%200920112013201520172019202120232025
ROE
FY2025 · ROE 5.2%
10%20%-5%-10%200920112013201520172019202120232025
Gross margin44.4%
Operating margin9.6%
Net margin5.5%
Return on assets3.4%
EBITDAUSD 155.9M

Each USD of equity produced 5 cents of profit this year.

Cash & shareholders
USD 39.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 48.4
50M100M-10M-20M200920112013201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 39.3
20M201320152016201720182019202020222025
Dividends paid—
Net buybacksUSD 39.3M
Share of profit73.0%
Consecutive raises—

USD 39.3M in buybacks — 73% of the year's profit went back to shareholders.

Total assetsUSD 1.8B
EquityUSD 1.3B
CashUSD 380.9M
Gross debtUSD 250.8M
Net debtUSD -130.0M
Current ratio3.69×

The company holds more cash than debt.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B1.00.90.90.90.70.60.60.60.50.40.40.40.30.20.30.30.3
Operating income $B0.10.10.10.10.10.10.10.10.10.00.0−0.00.00.00.00.0−0.0
EBITDA $B0.20.20.20.20.10.10.10.10.10.10.00.00.00.00.10.1−0.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.0−0.00.0−0.00.00.0−0.0
Net income $B0.10.10.10.10.10.00.00.00.10.00.0−0.00.00.00.0−0.0−0.1
Free cash flow $B0.00.10.10.10.10.10.10.10.10.00.00.00.00.00.0−0.0−0.0
EPS, diluted $1.471.772.022.061.411.251.151.431.130.631.02−0.700.210.580.86−0.03−4.48
Dividend / sh $·················
Payout %·················
ROE %5.29.011.713.510.110.010.414.421.18.715.6−10.73.18.915.0−0.4·
Shares out B0.040.040.040.040.040.040.040.030.030.030.030.030.030.030.030.03·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 1 failures in 83 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 12 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente1 failures
ActivityMiscellaneous Electrical Machinery, Equipment & Supplies
Listed onNASDAQ
Incorporated inoutside the United States — SEC code A3
Fiscal year endsDecember 31
Data on record since2009

Share this section

Download image